Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #M13-365: A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination with Rituximab in Subjects with Relapsed Chronic Lymphocytic Leukemia
Ma, Shuo
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
6/29/12
→
2/25/24
Funding
Abbott Laboratories
((OE) Prot# M13-365)
View all
View less